To further evaluate the statistical epistasis between CD33 rs3865444 A and HLA-DRB1*15:01 alleles, we performed an interaction SF analysis and assessed the risk of developing MS in subjects carrying either one of these traits or both when compared to subjects negative for both alleles. The gene discussed is CD33; the disease is myeloid sarcoma.